An outline of measurement uncertainty of total protein in urine estimated according to the ISO Technical Specification 20914

Articles in the same Issue

1. Frontmatter
2. Editorial
3. Analytical performance specifications – moving from models to practical recommendations
4. Opinion Papers
5. What the Milan conference has taught us about analytical performance specification model definition and measurand allocation
6. The role of analytical performance specifications in international guidelines and standards dealing with metrological traceability in laboratory medicine
7. How clinical laboratories select and use Analytical Performance Specifications (APS) in Italy
8. Outcome-based analytical performance specifications: current status and future challenges
9. Analytical performance specifications based on biological variation data – considerations, strengths and limitations
10. State-of-the-art model for derivation of analytical performance specifications: how to define the highest level of analytical performance technically achievable
11. Analytical performance specifications for combined uncertainty budget in the implementation of metrological traceability
12. When bias becomes part of imprecision: how to use analytical performance specifications to determine acceptability of lot-lot variation and other sources of possibly unacceptable bias
13. Using analytical performance specifications in a medical laboratory
14. Issues in assessing analytical performance specifications in healthcare systems assembling multiple laboratories and measuring systems
15. Applying the Milan models to setting analytical performance specifications – considering all the information
16. Guidelines and Recommendations
17. Recommendations for blood sampling in emergency departments from the European Society for Emergency Medicine (EUSEM), European Society for Emergency Nursing (EuSEN), and European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase. Executive summary
18. General Clinical Chemistry and Laboratory Medicine
19. Assessment of accuracy of laboratory testing results, relative to peer group consensus values in external quality control, by bivariate z-score analysis: the example of D-Dimer
20. The stability of 65 biochemistry analytes in plasma, serum, and whole blood
21. Assessment of the 2023 European Kidney Function Consortium (EKFC) equations in a Chinese adult population
22. In vitro, in vivo metabolism and quantification of the novel synthetic opioid N-piperidinyl etonitazene (etonitazepipne)
23. Quantification of blood glial fibrillary acidic protein using a second-generation microfluidic assay. Validation and comparative analysis with two established assays
24. Association of prehospital lactate levels with base excess in various emergencies – a retrospective study
25. Reference Values and Biological Variations
26. Stability of ten serum tumor markers after one year of storage at −18°C
27. Variations in tumor growth, intra-individual biological variability, and the interpretation of changes
28. Cancer Diagnostics
29. N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myeloma
30. Cardiovascular Diseases
31. Reference intervals for high sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide in children and adolescents on the Siemens Atellica
32. Infectious Diseases
33. Fetal chronic hypoxia does not affect urinary presepsin levels in newborns at birth
34. Letters to the Editor
35. AWMF statement on medical services in laboratory diagnostics and pathology with regard to the IVDR
36. An outline of measurement uncertainty of total protein in urine estimated according to the ISO Technical Specification 20914
37. Early diagnosis of severe illness in an outpatient – the Sysmex XN’s neutrophil reactivity parameter
38. Analytical and diagnostic performance of Theradiag i-Tracker assays on IDS-iSYS for infliximab and adalimumab therapeutic drug monitoring
39. Improving the diagnosis of AATD with aid of serum protein electrophoresis: a prospective, multicentre, validation study
40. Cerebrospinal fluid kappa free light chains in patients with tumefactive demyelination
41. Diagnostic value of quantitative chemiluminescence immunoassay for anti-gp210 and anti-sp100 antibodies in primary biliary cholangitis